Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 5
Submit an article Journal homepage
815
Views
35
CrossRef citations to date
0
Altmetric
Point of View

Fusions between dendritic cells and whole tumor cells as anticancer vaccines

Shigeo Koido Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan; Institute of Clinical Medicine and Research; The Jikei University School of Medicine; Tokyo, Japan; Department of Oncology, Institute of DNA Medicine; The Jikei University School of Medicine; Tokyo, JapanCorrespondence[email protected]
,
Sadamu Homma Department of Oncology, Institute of DNA Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Masato Okamoto Division of Cellular Signaling; Institute for Advanced Medical Research; Keio University School of Medicine; Tokyo, Japan
,
Yoshihisa Namiki Institute of Clinical Medicine and Research; The Jikei University School of Medicine; Tokyo, Japan
,
Kazuki Takakura Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Kan Uchiyama Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Mikio Kajihara Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Seiji Arihiro Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Hiroo Imazu Department of Endoscopy; The Jikei University School of Medicine; Tokyo, Japan
,
Hiroshi Arakawa Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan; Department of Endoscopy; The Jikei University School of Medicine; Tokyo, Japan
,
Shin Kan Department of Oncology, Institute of DNA Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Hideo Komita Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan; Department of Oncology, Institute of DNA Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Masaki Ito Department of Oncology, Institute of DNA Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Toshifumi Ohkusa Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan
,
Jianlin Gong Department of Medicine; Boston University School of Medicine; Boston, MA USA
&
Hisao Tajiri Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan
 show all
Article: e24437 | Received 09 Mar 2013, Accepted 25 Mar 2013, Published online: 01 May 2013

References

  • Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271 - 96; http://dx.doi.org/10.1146/annurev.iy.09.040191.001415; PMID: 1910679
  • Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998; 4:328 - 32; http://dx.doi.org/10.1038/nm0398-328; PMID: 9500607
  • Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr.. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 1996; 183:283 - 7; http://dx.doi.org/10.1084/jem.183.1.283; PMID: 8551233
  • Phan V, Errington F, Cheong SC, Kottke T, Gough M, Altmann S, et al. A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Nat Med 2003; 9:1215 - 9; http://dx.doi.org/10.1038/nm923; PMID: 12925849
  • Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996; 183:317 - 22; http://dx.doi.org/10.1084/jem.183.1.317; PMID: 8551239
  • Russo V, Tanzarella S, Dalerba P, Rigatti D, Rovere P, Villa A, et al. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. Proc Natl Acad Sci U S A 2000; 97:2185 - 90; http://dx.doi.org/10.1073/pnas.040540197; PMID: 10681453
  • Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997; 3:558 - 61; http://dx.doi.org/10.1038/nm0597-558; PMID: 9142127
  • Gong J, Koido S, Calderwood SK. Cell fusion: from hybridoma to dendritic cell-based vaccine. Expert Rev Vaccines 2008; 7:1055 - 68; http://dx.doi.org/10.1586/14760584.7.7.1055; PMID: 18767954
  • Koido S, Tanaka Y, Chen D, Kufe D, Gong J. The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic/tumor fusion cells in MUC1-transgenic mice. J Immunol 2002; 168:2111 - 7; PMID: 11859096
  • Koido S, Ohana M, Liu C, Nikrui N, Durfee J, Lerner A, et al. Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation. Clin Immunol 2004; 113:261 - 9; http://dx.doi.org/10.1016/j.clim.2004.08.004; PMID: 15507391
  • Koido S, Gong J. Characterization of structure and direct antigen presentation by dendritic/tumor-fused cells as cancer vaccines. Anticancer Res 2013; 33:347 - 54; PMID: 23393323
  • Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, et al. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Clin Cancer Res 2005; 11:7891 - 900; http://dx.doi.org/10.1158/1078-0432.CCR-05-1330; PMID: 16278414
  • Koido S, Homma S, Hara E, Namiki Y, Takahara A, Komita H, et al. Regulation of tumor immunity by tumor/dendritic cell fusions. Clin Dev Immunol 2010; 2010:516768; http://dx.doi.org/10.1155/2010/516768; PMID: 21048993
  • Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Takahara A, et al. Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes. PLoS ONE 2013; 8:e59280; http://dx.doi.org/10.1371/journal.pone.0059280
  • Koido S, Hara E, Homma S, Torii A, Mitsunaga M, Yanagisawa S, et al. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells. J Immunol 2007; 178:613 - 22; PMID: 17182602
  • Koido S, Hara E, Homma S, Mitsunaga M, Takahara A, Nagasaki E, et al. Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells. J Immunol 2007; 179:4874 - 83; PMID: 17878387

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.